Chris O'Meara, Associated Press
NEW BRUNSWICK, N.J. — Johnson & Johnson says its first-quarter profit rose 8 percent, because of restrained costs and a big jump in prescription drug sales. The world's biggest maker of health care products easily beat Wall Street expectations and raised its earnings outlook.
The maker of Tylenol, medical devices and prescription drugs said Tuesday that net income was $4.73 billion, or $1.64 per share, up from $3.5 billion, or $1.22 per share, a year earlier.
Excluding one-time items, income was $4.43 billion, or $1.54 per share. Analysts surveyed by FactSet expected $1.48.
Revenue totaled $18.12 billion, up 3.5 percent. Analysts expected $18.04 billion.
The company, based in New Brunswick, N.J., raised its profit forecast for 2014 to $5.80 to $5.90 per share. In January, J&J forecast $5.75 to $5.85.
- Rare cancer treatment leaves Provo teen hopeful
- West Nile activity discovered in four Utah...
- Propaganda war continues in Hobby Lobby...
- Understanding and responding to the increase...
- Medicaid enrollees strain Oregon; state...
- Controlling the silent killer
- Appeals courts issue contradictory rulings on...
- Conflicting court rulings may slow Medicaid...
- Propaganda war continues in Hobby Lobby... 50
- Appeals courts issue contradictory... 48
- Understanding and responding to the... 9
- Medicaid enrollees strain Oregon; state... 7
- Conflicting court rulings may slow... 5
- Joseph Cramer, M.D.: You're not in... 2
- Obama nominee Robert McDonald pledges... 1
- Varying health premium subsidy amounts... 1